BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22862733)

  • 1. Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function.
    Hey YY; O'Neill HC
    J Cell Mol Med; 2012 Nov; 16(11):2611-9. PubMed ID: 22862733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presenting capacity of murine splenic myeloid cells.
    Hey YY; Quah B; O'Neill HC
    BMC Immunol; 2017 Jan; 18(1):4. PubMed ID: 28077081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematopoietic stem cells in spleen have distinct differentiative potential for antigen presenting cells.
    Tan JK; O'Neill HC
    J Cell Mol Med; 2010 Aug; 14(8):2144-50. PubMed ID: 19799644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel antigen cross-presenting cell type in spleen.
    Tan JK; Quah BJ; Griffiths KL; Periasamy P; Hey YY; O'Neill HC
    J Cell Mol Med; 2011 May; 15(5):1189-99. PubMed ID: 20477902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen.
    Ryu SH; Shin HS; Eum HH; Park JS; Choi W; Na HY; In H; Kim TG; Park S; Hwang S; Sohn M; Kim ED; Seo KY; Lee HO; Lee MG; Chu MK; Park CG
    Front Immunol; 2021; 12():767037. PubMed ID: 35069539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel myeloid cell in murine spleen defined through gene profiling.
    Hey YY; O'Neill TJ; O'Neill HC
    J Cell Mol Med; 2019 Aug; 23(8):5128-5143. PubMed ID: 31210415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of endocytosis, degradative activity, and antigen processing capacity during GM-CSF driven differentiation of murine bone marrow.
    Olatunde AC; Abell LP; Landuyt AE; Hiltbold Schwartz E
    PLoS One; 2018; 13(5):e0196591. PubMed ID: 29746488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine dendritic cell antigen-presenting cell function is not altered by burn injury.
    Fujimi S; Lapchak PH; Zang Y; MacConmara MP; Maung AA; Delisle AJ; Mannick JA; Lederer JA
    J Leukoc Biol; 2009 May; 85(5):862-70. PubMed ID: 19228816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-Presenting Cells in the Skin.
    Kashem SW; Haniffa M; Kaplan DH
    Annu Rev Immunol; 2017 Apr; 35():469-499. PubMed ID: 28226228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
    Nierkens S; Tel J; Janssen E; Adema GJ
    Trends Immunol; 2013 Aug; 34(8):361-70. PubMed ID: 23540650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental models linking dendritic cell lineage, phenotype and function.
    Fazekas De St Groth B; L Smith A; Bosco J; Sze DM; Power CA; Austen FI
    Immunol Cell Biol; 2002 Oct; 80(5):469-76. PubMed ID: 12225383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing human peripheral blood CD16
    Fromm PD; Silveira PA; Hsu JL; Papadimitrious MS; Lo TH; Ju X; Kupresanin F; Romano A; Hsu WH; Bryant CE; Kong B; Abadir E; Mekkawy A; M McGuire H; Groth BFS; Cunningham I; Newman E; Gibson J; Hogarth PM; Hart DNJ; Clark GJ
    J Leukoc Biol; 2020 Feb; 107(2):323-339. PubMed ID: 31749181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
    Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
    PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm.
    Villadangos JA; Heath WR
    Semin Immunol; 2005 Aug; 17(4):262-72. PubMed ID: 15946854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competent antigen-presenting cells are generated from the long-term culture of splenocytes with granulocyte-macrophage colony-stimulating factor.
    Ryu SH; Na HY; Sohn M; Choi W; In H; Shin HS; Choi JH; Park CG
    Immunol Lett; 2017 Aug; 188():96-107. PubMed ID: 28673654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses.
    Arnold CE; Gordon P; Barker RN; Wilson HM
    Immunobiology; 2015 Jan; 220(1):10-9. PubMed ID: 25454489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerin
    Backer RA; Diener N; Clausen BE
    Front Immunol; 2019; 10():741. PubMed ID: 31031751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
    Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
    Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.
    Wacleche VS; Tremblay CL; Routy JP; Ancuta P
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29415518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.